{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:32:26Z","timestamp":1787499146681,"version":"build-2736575974"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T00:00:00Z","timestamp":1535932800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T00:00:00Z","timestamp":1535932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Oral Sci"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Bone wound healing is a highly dynamic and precisely controlled process through which damaged bone undergoes repair and complete regeneration. External factors can alter this process, leading to delayed or failed bone wound healing. The findings of recent studies suggest that the use of selective serotonin reuptake inhibitors (SSRIs) can reduce bone mass, precipitate osteoporotic fractures and increase the rate of dental implant failure. With 10% of Americans prescribed antidepressants, the potential of SSRIs to impair bone healing may adversely affect millions of patients\u2019 ability to heal after sustaining trauma. Here, we investigate the effect of the SSRI sertraline on bone healing through pre-treatment with (10\u2009mg\u00b7kg\n                    <jats:sup>-1<\/jats:sup>\n                    sertraline in drinking water,\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200926) or without (control,\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200930) SSRI followed by the creation of a 5-mm calvarial defect. Animals were randomized into three surgical groups: (a) empty\/sham, (b) implanted with a DermaMatrix scaffold soak-loaded with sterile PBS or (c) DermaMatrix soak-loaded with 542.5\u2009ng BMP2. SSRI exposure continued until sacrifice\u00a0in the exposed groups at\u00a04 weeks after surgery. Sertraline exposure resulted in decreased bone healing with significant decreases in trabecular thickness, trabecular number and osteoclast dysfunction while significantly increasing mature collagen fiber\u00a0formation. These findings indicate that sertraline exposure can impair bone wound healing through disruption of bone repair and regeneration while promoting or defaulting to scar formation within the defect site.\n                  <\/jats:p>","DOI":"10.1038\/s41368-018-0026-x","type":"journal-article","created":{"date-parts":[[2018,7,26]],"date-time":"2018-07-26T04:59:16Z","timestamp":1532581156000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Selective serotonin re-uptake inhibitor sertraline inhibits bone healing in a calvarial defect model"],"prefix":"10.1038","volume":"10","author":[{"given":"R. Nicole","family":"Howie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Herberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Durham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Grey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Bennfors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Elsalanty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda C.","family":"LaRue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Cray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,3]]},"reference":[{"key":"26_CR1","unstructured":"Pratt, L. A., Brody, D. J. & Gu, Q. Antidepressant use in persons aged 12 and over: United States, 2005-2008. NCHS Data Brief 76 1\u20138 (2011)."},{"key":"26_CR2","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s00223-011-9481-5","volume":"88","author":"SJ Diem","year":"2011","unstructured":"Diem, S. J. et al. Use of antidepressant medications and risk of fracture in older women. Calcif. Tissue Int. 88, 476\u2013484 (2011).","journal-title":"Calcif. Tissue Int."},{"key":"26_CR3","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/nau.21182","volume":"31","author":"B Gu","year":"2012","unstructured":"Gu, B., Wu, G., Si, J., Xu, Y. & Andersson, K. E. Improving voiding efficiency in the diabetic rat by a 5-HT1A serotonin receptor agonist. Neurourol. Urodyn. 31, 168\u2013173 (2012).","journal-title":"Neurourol. Urodyn."},{"key":"26_CR4","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/clpt.2011.54","volume":"89","author":"JJ Gagne","year":"2011","unstructured":"Gagne, J. J., Patrick, A. R., Mogun, H. & Solomon, D. H. Antidepressants and fracture risk in older adults: a comparative safety analysis. Clin. Pharmacol. Ther. 89, 880\u2013887 (2011).","journal-title":"Clin. Pharmacol. Ther."},{"key":"26_CR5","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/s00296-012-2461-x","volume":"33","author":"O Bruyere","year":"2013","unstructured":"Bruyere, O. et al. Perception, knowledge, and use by general practitioners of Belgium of a new WHO tool (FRAX) to assess the 10-year probability of fracture. Rheumatol. Int. 33, 979\u2013983 (2013).","journal-title":"Rheumatol. Int."},{"key":"26_CR6","first-page":"357","volume":"24","author":"R Okazaki","year":"2014","unstructured":"Okazaki, R. Fracture risk associated with drugs other than glucocorticoids. Clin. Calcium 24, 357\u2013365 (2014).","journal-title":"Clin. Calcium"},{"key":"26_CR7","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.maturitas.2014.05.019","volume":"78","author":"LM Moberg","year":"2014","unstructured":"Moberg, L. M., Nilsson, P. M., Samsioe, G. & Borgfeldt, C. Use of proton pump inhibitors (PPI) and history of earlier fracture are independent risk factors for fracture in postmenopausal women. The WHILA study. Maturitas 78, 310\u2013315 (2014).","journal-title":"Maturitas"},{"key":"26_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2015.38","volume":"5","author":"PW Gold","year":"2015","unstructured":"Gold, P. W. et al. Chronic administration of anticonvulsants but not antidepressants impairs bone strength: clinical implications. Transl. Psychiatry 5, e576 (2015).","journal-title":"Transl. Psychiatry"},{"key":"26_CR9","doi-asserted-by":"publisher","first-page":"E1732","DOI":"10.1210\/jc.2014-2288","volume":"99","author":"SJ Diem","year":"2014","unstructured":"Diem, S. J. et al. Effects of escitalopram on markers of bone turnover: a randomized clinical trial. J. Clin. Endocrinol. Metab. 99, E1732\u2013E1737 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"26_CR10","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s40263-015-0231-5","volume":"29","author":"A Lanteigne","year":"2015","unstructured":"Lanteigne, A. et al. Serotonin-norepinephrine reuptake inhibitor and selective serotonin reuptake inhibitor use and risk of fractures: a new-user cohort study among US adults aged 50 years and older. CNS Drugs 29, 245\u2013252 (2015).","journal-title":"CNS Drugs"},{"key":"26_CR11","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1007\/s00198-012-2170-z","volume":"24","author":"ML Shea","year":"2013","unstructured":"Shea, M. L. et al. Serotonin-norepinephrine reuptake inhibitor therapy in late-life depression is associated with increased marker of bone resorption. Osteoporos. Int. 24, 1741\u20131749 (2013).","journal-title":"Osteoporos. Int."},{"key":"26_CR12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00198-012-2015-9","volume":"24","author":"V Rabenda","year":"2013","unstructured":"Rabenda, V., Nicolet, D., Beaudart, C., Bruyere, O. & Reginster, J. Y. Relationship between use of antidepressants and risk of fractures: a meta-analysis. Osteoporos. Int. 24, 121\u2013137 (2013).","journal-title":"Osteoporos. Int."},{"key":"26_CR13","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s00198-011-1778-8","volume":"23","author":"Q Wu","year":"2012","unstructured":"Wu, Q., Bencaz, A. F., Hentz, J. G. & Crowell, M. D. Selective serotonin reuptake inhibitor treatment and risk of fractures: a meta-analysis of cohort and case-control studies. Osteoporos. Int. 23, 365\u2013375 (2012).","journal-title":"Osteoporos. Int."},{"key":"26_CR14","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1136\/injuryprev-2014-041483","volume":"21","author":"YH Sheu","year":"2015","unstructured":"Sheu, Y. H. et al. SSRI use and risk of fractures among perimenopausal women without mental disorders. Inj. Prev. 21, 397\u2013403 (2015).","journal-title":"Inj. Prev."},{"key":"26_CR15","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1002\/jbmr.3045","volume":"32","author":"V Bradaschia-Correa","year":"2017","unstructured":"Bradaschia-Correa, V. et al. The selective serotonin reuptake inhibitor fluoxetine directly inhibits osteoblast differentiation and mineralization during fracture healing in mice. J. Bone Miner. Res. 32, 821\u2013833 (2017).","journal-title":"J. Bone Miner. Res."},{"key":"26_CR16","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1146\/annurev-med-090710-133426","volume":"62","author":"G Karsenty","year":"2011","unstructured":"Karsenty, G. & Yadav, V. K. Regulation of bone mass by serotonin: molecular biology and therapeutic implications. Annu. Rev. Med. 62, 323\u2013331 (2011).","journal-title":"Annu. Rev. Med."},{"key":"26_CR17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.biopsych.2012.11.003","volume":"74","author":"JM Hodge","year":"2013","unstructured":"Hodge, J. M. et al. Selective serotonin reuptake inhibitors inhibit human osteoclast and osteoblast formation and function. Biol. Psychiatry 74, 32\u201339 (2013).","journal-title":"Biol. Psychiatry"},{"key":"26_CR18","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1302\/0301-620X.95B11.31158","volume":"95-B","author":"M Salai","year":"2013","unstructured":"Salai, M. et al. Effects of commonly used medications on bone tissue mineralisation in SaOS-2 human bone cell line: an in vitro study. Bone Jt. J. 95-B, 1575\u20131580 (2013).","journal-title":"Bone Jt. J."},{"key":"26_CR19","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1002\/bdra.23323","volume":"100","author":"JJ Cray Jr.","year":"2014","unstructured":"Cray, J. J. Jr. et al. Selective serotonin reuptake inhibitor exposure alters osteoblast gene expression and craniofacial development in mice. Birth Defects Res. A Clin. Mol. Teratol. 100, 912\u2013923 (2014).","journal-title":"Birth Defects Res. A Clin. Mol. Teratol."},{"key":"26_CR20","unstructured":"Burt, C. W. & Fingerhut, L. A. Injury visits to hospital emergency departments: United States, 1992-95. Vital Health Stat. 13 131, 1\u201376 (1998)."},{"key":"26_CR21","doi-asserted-by":"publisher","first-page":"S86","DOI":"10.1016\/j.amepre.2009.10.016","volume":"38","author":"TA Mitchener","year":"2010","unstructured":"Mitchener, T. A. & Canham-Chervak, M. Oral-maxillofacial injury surveillance in the Department of Defense, 1996-2005. Am. J. Prev. Med. 38, S86\u2013S93 (2010).","journal-title":"Am. J. Prev. Med."},{"key":"26_CR22","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/j.1600-0528.1979.tb01182.x","volume":"7","author":"RV Katz","year":"1979","unstructured":"Katz, R. V., Barnes, G. P., Larson, H. R., Lyon, T. C. & Brunner, D. G. Epidemiologic survey of accidental dentofacial injuries among U.S. Army personnel. Community Dent. Oral. Epidemiol. 7, 30\u201336 (1979).","journal-title":"Community Dent. Oral. Epidemiol."},{"key":"26_CR23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/S0033-3549(04)50212-1","volume":"118","author":"CB Snowden","year":"2003","unstructured":"Snowden, C. B., Miller, T. R., Jensen, A. F. & Lawrence, B. A. Costs of medically treated craniofacial conditions. Public Health Rep. 118, 10\u201317 (2003).","journal-title":"Public Health Rep."},{"key":"26_CR24","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.cden.2005.11.003","volume":"50","author":"DC Wan","year":"2006","unstructured":"Wan, D. C., Nacamuli, R. P. & Longaker, M. T. Craniofacial bone tissue engineering. Dent. Clin. North Am. 50, 175\u2013190 (2006). vii.","journal-title":"Dent. Clin. North Am."},{"key":"26_CR25","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.cps.2004.03.001","volume":"31","author":"YR Cho","year":"2004","unstructured":"Cho, Y. R. & Gosain, A. K. Biomaterials in craniofacial reconstruction. Clin. Plast. Surg. 31, 377\u2013385 (2004). v.","journal-title":"Clin. Plast. Surg."},{"key":"26_CR26","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1177\/0022034514549378","volume":"93","author":"X Wu","year":"2014","unstructured":"Wu, X. et al. Selective serotonin reuptake inhibitors and the risk of osseointegrated implant failure: a cohort study. J. Dent. Res. 93, 1054\u20131061 (2014).","journal-title":"J. Dent. Res."},{"key":"26_CR27","doi-asserted-by":"publisher","first-page":"50","DOI":"10.5125\/jkaoms.2014.40.2.50","volume":"40","author":"L Gaviria","year":"2014","unstructured":"Gaviria, L., Salcido, J. P., Guda, T. & Ong, J. L. Current trends in dental implants. J. Korean Assoc. Oral. Maxillofac. Surg. 40, 50\u201360 (2014).","journal-title":"J. Korean Assoc. Oral. Maxillofac. Surg."},{"key":"26_CR28","volume-title":"Oral and Maxillofacial Surgerons: The Experts in Face, Mouth and Jaw Surgery","author":"American Association of Oral and Maxillofacial Surgeons.","year":"2014","unstructured":"American Association of Oral and Maxillofacial Surgeons. Oral and Maxillofacial Surgerons: The Experts in Face, Mouth and Jaw Surgery (Rosemount, IL, 2014)."},{"key":"26_CR29","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1002\/term.2078","volume":"11","author":"S Herberg","year":"2017","unstructured":"Herberg, S. et al. Mesenchymal stem cell expression of SDF-1beta synergizes with BMP-2 to augment cell-mediated healing of critical-sized mouse calvarial defects. J. Tissue Eng. Regen. Med. 11, 1806\u20131819 (2017).","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"26_CR30","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.bone.2014.07.007","volume":"67","author":"S Herberg","year":"2014","unstructured":"Herberg, S. et al. Inkjet-based biopatterning of SDF-1beta augments BMP-2-induced repair of critical size calvarial bone defects in mice. Bone 67, 95\u2013103 (2014).","journal-title":"Bone"},{"key":"26_CR31","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1097\/PRS.0b013e3181cb63a3","volume":"125","author":"GM Cooper","year":"2010","unstructured":"Cooper, G. M. et al. Testing the critical size in calvarial bone defects: revisiting the concept of a critical-size defect. Plast. Reconstr. Surg. 125, 1685\u20131692 (2010).","journal-title":"Plast. Reconstr. Surg."},{"key":"26_CR32","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1038\/nm.4166","volume":"22","author":"MJ Ortuno","year":"2016","unstructured":"Ortuno, M. J. et al. Serotonin-reuptake inhibitors act centrally to cause bone loss in mice by counteracting a local anti-resorptive effect. Nat. Med. 22, 1170\u20131179 (2016).","journal-title":"Nat. Med."},{"key":"26_CR33","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1097\/BOR.0b013e3282ff0d6d","volume":"20","author":"J Allport","year":"2008","unstructured":"Allport, J. Incidence and prevalence of medication-induced osteoporosis: evidence-based review. Curr. Opin. Rheumatol. 20, 435\u2013441 (2008).","journal-title":"Curr. Opin. Rheumatol."},{"key":"26_CR34","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2165\/00002512-199812010-00005","volume":"12","author":"RG Cumming","year":"1998","unstructured":"Cumming, R. G. Epidemiology of medication-related falls and fractures in the elderly. Drugs Aging 12, 43\u201353 (1998).","journal-title":"Drugs Aging"},{"key":"26_CR35","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1001\/archinte.167.12.1246","volume":"167","author":"EM Haney","year":"2007","unstructured":"Haney, E. M. et al. Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men. Arch. Intern. Med. 167, 1246\u20131251 (2007).","journal-title":"Arch. Intern. Med."},{"key":"26_CR36","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1001\/archinte.167.2.188","volume":"167","author":"JB Richards","year":"2007","unstructured":"Richards, J. B. et al. Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch. Intern. Med. 167, 188\u2013194 (2007).","journal-title":"Arch. Intern. Med."},{"key":"26_CR37","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/YIC.0b013e3282f2b3bb","volume":"23","author":"LJ Williams","year":"2008","unstructured":"Williams, L. J. et al. Selective serotonin reuptake inhibitor use and bone mineral density in women with a history of depression. Int. Clin. Psychopharmacol. 23, 84\u201387 (2008).","journal-title":"Int. Clin. Psychopharmacol."},{"key":"26_CR38","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.abb.2008.03.016","volume":"473","author":"F Elefteriou","year":"2008","unstructured":"Elefteriou, F. Regulation of bone remodeling by the central and peripheral nervous system. Arch. Biochem. Biophys. 473, 231\u2013236 (2008).","journal-title":"Arch. Biochem. Biophys."},{"key":"26_CR39","doi-asserted-by":"crossref","first-page":"421","DOI":"10.33549\/physiolres.932668","volume":"63","author":"I Zofkova","year":"2014","unstructured":"Zofkova, I. & Matucha, P. New insights into the physiology of bone regulation: the role of neurohormones. Physiol. Res. 63, 421\u2013427 (2014).","journal-title":"Physiol. Res."},{"key":"26_CR40","first-page":"1","volume":"1","author":"ML Johnson","year":"2012","unstructured":"Johnson, M. L. LRP5 and bone mass regulation: where are we now? Bone Rep. 1, 1 (2012).","journal-title":"Bone Rep."},{"key":"26_CR41","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1297\/cpe.19.49","volume":"19","author":"T Kubota","year":"2010","unstructured":"Kubota, T., Michigami, T. & Ozono, K. Wnt signaling in bone. Clin. Pediatr. Endocrinol. 19, 49\u201356 (2010).","journal-title":"Clin. Pediatr. Endocrinol."},{"key":"26_CR42","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1749-6632.2009.05312.x","volume":"1192","author":"VK Yadav","year":"2010","unstructured":"Yadav, V. K. & Ducy, P. Lrp5 and bone formation: a serotonin-dependent pathway. Ann. N. Y. Acad. Sci. 1192, 103\u2013109 (2010).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"26_CR43","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s11914-011-0086-8","volume":"10","author":"W Zhang","year":"2012","unstructured":"Zhang, W. & Drake, M. T. Potential role for therapies targeting DKK1, LRP5, and serotonin in the treatment of osteoporosis. Curr. Osteoporos. Rep. 10, 93\u2013100 (2012).","journal-title":"Curr. Osteoporos. Rep."},{"key":"26_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-10-151","volume":"10","author":"YF Hu","year":"2009","unstructured":"Hu, Y. F., Caron, M. G. & Sieber-Blum, M. Norepinephrine transport-mediated gene expression in noradrenergic neurogenesis. BMC Genomics 10, 151 (2009).","journal-title":"BMC Genomics"},{"key":"26_CR45","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1007\/s00198-012-1909-x","volume":"23","author":"C Zuo","year":"2012","unstructured":"Zuo, C. et al. Osteoblastogenesis regulation signals in bone remodeling. Osteoporos. Int. 23, 1653\u20131663 (2012).","journal-title":"Osteoporos. Int."},{"key":"26_CR46","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s00726-016-2320-2","volume":"49","author":"N Agnihotri","year":"2017","unstructured":"Agnihotri, N. & Mehta, K. Transglutaminase-2: evolution from pedestrian protein to a promising therapeutic target. Amino Acids 49, 425\u2013439 (2017).","journal-title":"Amino Acids"},{"key":"26_CR47","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/MED.0b013e32835bc703","volume":"20","author":"MD Gershon","year":"2013","unstructured":"Gershon, M. D. 5-Hydroxytryptamine (serotonin) in the gastrointestinal tract. Curr. Opin. Endocrinol. Diabetes Obes. 20, 14\u201321 (2013).","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"26_CR48","doi-asserted-by":"publisher","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","volume":"8","author":"C Kilkenny","year":"2010","unstructured":"Kilkenny, C., Browne, W. J., Cuthill, I. C., Emerson, M. & Altman, D. G. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 8, e1000412 (2010).","journal-title":"PLoS Biol."},{"key":"26_CR49","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1002\/jbmr.141","volume":"25","author":"ML Bouxsein","year":"2010","unstructured":"Bouxsein, M. L. et al. Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J. Bone Miner. Res. 25, 1468\u20131486 (2010).","journal-title":"J. Bone Miner. Res."},{"key":"26_CR50","doi-asserted-by":"publisher","first-page":"e96801","DOI":"10.1371\/journal.pone.0096801","volume":"9","author":"F Varghese","year":"2014","unstructured":"Varghese, F., Bukhari, A. B., Malhotra, R. & De, A. IHC profiler: an open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples. PLoS ONE 9, e96801 (2014).","journal-title":"PLoS ONE"},{"key":"26_CR51","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/bdra.23543","volume":"106","author":"EL Durham","year":"2016","unstructured":"Durham, E. L. et al. Effects of thyroxine exposure on the Twist 1+\/- phenotype: a test of gene-environment interaction modeling for craniosynostosis. Birth. Defects Res. A Clin. Mol. Teratol. 106, 803\u2013813 (2016).","journal-title":"Birth. Defects Res. A Clin. Mol. Teratol."},{"key":"26_CR52","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1359\/jbmr.080304","volume":"23","author":"W Zhang","year":"2008","unstructured":"Zhang, W. et al. Age-related changes in the osteogenic differentiation potential of mouse bone marrow stromal cells. J. Bone Miner. Res. 23, 1118\u20131128 (2008).","journal-title":"J. Bone Miner. Res."},{"key":"26_CR53","unstructured":"NIH. Toxicology Data Network: Sertraline (National Library of Medicine HSDB Database, Bethesda, MD, 2002)."},{"key":"26_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-7-85","volume":"7","author":"JS Yuan","year":"2006","unstructured":"Yuan, J. S., Reed, A., Chen, F. & Stewart, C. N. Jr. Statistical analysis of real-time PCR data. BMC Bioinforma. 7, 85 (2006).","journal-title":"BMC Bioinforma."}],"container-title":["International Journal of Oral Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41368-018-0026-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41368-018-0026-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41368-018-0026-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T05:54:44Z","timestamp":1671515684000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41368-018-0026-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,3]]},"references-count":54,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,9]]}},"alternative-id":["26"],"URL":"https:\/\/doi.org\/10.1038\/s41368-018-0026-x","relation":{},"ISSN":["2049-3169"],"issn-type":[{"value":"2049-3169","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,3]]},"assertion":[{"value":"30 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25"}}